Marko Marx China

equity investment
Website:
www.hqpeim.com
Partnering Objectives
Headquartner in China
Huaqian Capital management co
CEO 

Marko Marx China

Investnwnt business focus on start company of BT
Website:
Hqpeim.com
Partnering Objectives
Headquartner in China
Huaqian Capital
CEO 

Mr. Richard McCrae Canada

Kymeris has invented a revolutionary, live-cell based technology platform which delivers into the tumor micro-environment and activates there multiple therapeutic agents - including ligands, cytokines, and antibodies. Efficacy of anti-cancer action has been shown in 5 separate solid cancer indications with reduction in tumour size averaging 80% - but in many cases showing complete eradication. This game changing approach is of particular value to companies with proprietary molecules that are looking for safe and effective vectoring into tumors, and with whom we might partner.
Company Size (Fulltime employees)
Year of foundation
2016
Please specify your partnering goal
Out licensing
Headquartner in China
Biotech/Pharma Category
Kymeris therapeutics Inc
President & CEO 
Functionality

Michael McNeely United States

GattaCo develops products that enable fast accurate evidence-based decision making to improve healthcare outcomes. We do this by solving the fundamental problems in sample purification, the most challenging component of the diagnostic testing workflow.

 Our new Plasm™ Module is a revolutionary, patented, automatic plasma separation and metering module or insert used to provide high-purity, metered plasma to a rapid diagnostic testing platform, such as lateral flow, biosensor, or other Point of Care (POC) device, from finger-stick capillary blood. The initial version of the Plasm Module is optimized for antibody testing and will revolutionize POC diagnostics by improving: 

  • Sensitivity: Increased number of antibodies compared to the same volume of whole blood.
  • Specificity Accuracy: High quality/purity sample with reduced background.
  • Repeatability: Plasma is metered to +/- 5%.
  • Quantitation: Precisely metered output, independent of hematocrit.
Website:
www.gattaco.com
Year of foundation
2018
Headquartner in China
Biotech/Pharma Asset Stage
Medtech Category
Medtech Development Stage
GATTACO Inc.
Pres/CEO 
Functionality

Miss Yifan Meng China

对生物产业园进行开发;管理生物产业园相关载体;提供以生物技术为主的高新科技企业技术服务平台,提供化学产品、生物制品的分析检测服务,以及相关项目和产业的管理服务和咨询服务;非学历职业技能培训;对科技项目进行投资;
Company Size (Fulltime employees)
Please specify your partnering goal
了解行业动态,寻找潜在客户
Headquartner in China
苏州工业园区生物产业发展有限公司
Speciallist 
Functionality

Mr. Sam Meredith

Who We Are

An executive search and talent acquisition specialist with a wealth of experience in the life science business sector
An alternative to the generalist search firms that offer only general search services
Able to find the right talent for you with the right approach and understanding the complexity of the life science industry
Able to build pools helping our clients to attract a long term and sustainable talent pipeline for current and future requirements, placing your company ahead of competition

Partnering Objectives
Headquartner in China
Slides Deck
(pdf, 3.74MB)
Bioprogress
Vice President 
Functionality

Dr. Doreen Miao Canada

Ananda Devices is a biotech company specialized in in vitro assay developments. Leveraging our proprietary nano-organization technology, we have developed physiologically relevant in vitro models that generate predicative responses early on in the compound development processes, thereby accelerating compound discovery and de-risking key developmental investments.
Our nervous on-a-chip technology enables clients to perform drug screening, toxicity and efficacy testing up to 50x faster and 90% more cost-effective. We have 20+ years of experience in neuroscience and tissue engineering, and we have been a developer of unique devices to grow brain, spinal cord and innervated skin models for clients in 12 countries.

Our product:
NeuroHTSTM is a first-in-class high throughput screening (HTS) platform to rapidly cultivate over 3,000 CNS or PNS neurons/plate into physiologically relevant networks.
Its easy-to-use technology requires no additional equipment such as shakers and tubing.
It is compatible with most automation solutions, suitable for both and human/animal models

Our customized services:
Our core technology enables 4 types of innovative assay developments:
-Organization of cell and tissue types for reproducible and physiologically relevant in vitro testing
-Innervation of different tissues
-Miniaturization of existing models to increase throughput and sensitivity
-Development of complex co-culture models to mimic disease on-a-chip

Company Size (Fulltime employees)
Please specify your partnering goal
Looking for new partners and clients
Headquartner in China
Medtech Category
Your Research Tool and Service name
High throughput nervous system on-a-chip platform for compound screening and development
Target client type
Pharmaceutical companies, R and D institutions, contract research services, life science distributors
Slides Deck
(pdf, 2.5MB)
Ananda Devices
Business Director 
Functionality

Ms. SAMMY MU United Kingdom

i-bank
Website:
na
Company Size (Fulltime employees)
Partnering Objectives
Please specify your partnering goal
top 30 ch phar med companies
Headquartner in China
SW1AP
VP 
Functionality

Samuel Murphy

Salubris Biotherapeutics
CEO